ATR disruption leads to chromosomal fragmentation and early embryonic lethality by Brown, Eric J. & Baltimore, David
RESEARCH COMMUNICATION
ATR disruption leads to
chromosomal fragmentation
and early embryonic lethality
Eric J. Brown and David Baltimore1
California Institute of Technology, Division of Biology,
Pasadena, California 91125 USA
Although a small decrease in survival and increase in
tumor incidence was observed in ATR+/− mice, ATR−/−
embryos die early in development, subsequent to the
blastocyst stage and prior to 7.5 days p.c. In culture,
ATR−/− blastocysts cells continue to cycle into mitosis
for 2 days but subsequently fail to expand and die of
caspase-dependent apoptosis. Importantly, caspase-inde-
pendent chromosome breaks are observed in ATR−/−
cells prior to widespread apoptosis, implying that apop-
tosis is caused by a loss of genomic integrity. These data
show that ATR is essential for early embryonic develop-
ment and must function in processes other than regula-
tion of p53.
Received November 16, 1999; revised version accepted
January 10, 2000.
ATM and ATR are mammalian counterparts to a family
of high molecular weight protein kinases conserved in a
broad range of species including Schizosaccharomyces
pombe, Saccharomyces cerevisiae, and Drosophila me-
lanogaster (Keith and Schreiber 1995; Keegan et al. 1996;
Cimprich et al. 1996; Canman et al. 1998). The genes
most closely related to ATM and ATR are the MEC1 (S.
cerevisiae) TEL1 (S. cerevisiae), RAD3 (S. pombe), and
Mei-41 (D. melanogaster) genes. Each of these genes is
involved in DNA damage responses and falls into two
groups based both on homology and function. ATM is
related most closely to TEL1, a gene that shares an over-
lapping role with MEC1 in checkpoint responses to g-ir-
radiation in S. cerevisiae (Morrow et al. 1995). ATR, on
the other hand, is most closely related to RAD3, Mei-41,
and MEC1 in descending order of similarity. The kinase
domain of ATR is 61% and 53% identical to the kinase
domains of RAD3 and Mei-41, respectively (Keith and
Schreiber 1995; Cimprich et al. 1996; Keegan et al. 1996),
whereas the ATM kinase domain shares only 39% iden-
tity with either RAD3 or Mei-41.
Recent studies indicate that ATR functions in DNA
damage response pathways similar to those mediated by
RAD3, Mei-41, and MEC1. RAD3, Mei-41, and MEC1 are
required for checkpoint responses to pyrimidine dimer
formation (UV radiation), DNA-alkylation (MMS), deple-
tion of deoxyribonucleotides [hydroxyurea (HU)] and
g-irradiation (Weinert et al. 1994; Hari et al. 1995; Bent-
ley et al. 1996). In addition to cell cycle checkpoint re-
sponse, these genes have been implicated in the regula-
tion of DNA repair (Weinert 1998). Consistent with the
hypothesis that ATR is the functional mammalian ho-
molog of RAD3, Mei-41, and MEC1, expression of a ki-
nase inactive mutant of ATR (ATR–KI) sensitizes mam-
malian cells to these same forms of DNA damage and
diminishes the G2/M checkpoint response induced by
g-irradiation (Cliby et al. 1998; Wright et al. 1998). Re-
cently, this ATR–KI cell line has been shown to be defi-
cient in the regulated phosphorylation of p53 in response
to UV and g-irradiation (Tibbetts et al. 1999). Because
ATM-disrupted cells are deficient in regulating p53 lev-
els in response to g-irradiation but not in response to UV
or MMS (Canman et al. 1994; Xu and Baltimore 1996),
ATR and ATM may possess both overlapping and nonre-
dundant roles in regulating p53 (Canman et al. 1998;
Tibbetts et al. 1999).
Here, we describe the phenotype of mice deficient in
ATR. Whereas ATR+/− mice display a small decrease in
survival and increase in tumor incidence, ATR−/− em-
bryos die early in development. Early embryonic lethal-
ity and observations of ATR−/− blastocysts cultured in
vitro indicate that ATR has an essential role in the pro-
liferation of early embryonic cells. In addition, we show
that ATR−/− cultured blastocyst cells suffer chromosom-
al fragmentation, suggesting that that the early death of
ATR−/− embryos is caused by a widespread loss of geno-
mic integrity. Because ATM−/− and p53−/− mice do not
display a similar phenotype, these data indicate that
ATR must function in some manner that is not redun-
dant with ATM and is independent of p53 regulation.
Evidence in support of a role for ATR in regulation of the
BRCA gene products and in S- to M-phase transition of
early embryonic cells is discussed.
Results
ATR disruption
Targeted disruption of ATR was achieved by deletion of
three exons encoding the translation initiating methio-
nine and the following 90 amino acids (Fig. 1A). Homolo-
gous recombination of the targeting vector into the ATR
gene introduces a neomycin resistance cassette contain-
ing a single EcoRV site (Fig. 1A). This EcoRV site was
subsequently used for colony screening by Southern blot
(Fig. 1B) and the genotype of positive clones was con-
firmed further by PCR (Fig. 1C). Chimeric mice originat-
ing from three different ES cell clones transmitted the
ATR disruption to F1 offspring. Although quantitation of
ATR mRNA in homozygous ATR-disrupted cells was
not possible due to early embryonic lethality (below), ES
cells and murine embryonic fibroblasts (MEFs) with a
single ATR allele disrupted expressed 47% ± 7% (95%
confidence interval) and 46% ± 10% less ATR mRNA,
respectively (Fig. 1D). Truncated mRNA species in
ATR+/− cells were not observed (Fig. 1D). Preliminary
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analysis of the effects of MMS, cisplatin, g-irradiation,
and HU on heterozygous ES cells and MEFs showed no
significant differences in the survival of ATR+/+ and
ATR+/− cells (data not shown).
Increase in tumor incidence in ATR+/− mice
Although p53+/− mice exhibit decreased longevity and
increased tumor incidence (Jacks et al. 1994), ATM+/−
mice survive similarly to wild-type mice (Barlow et al.
1999; C. Barlow, pers. comm.). Because ATR and ATM
are speculated to have both overlapping and nonredun-
dant roles in regulating p53, we asked whether the lon-
gevity of ATR+/− mice is compromised. ATR+/− and
ATM+/− mice (Xu and Baltimore 1996) were crossed to
produce populations of ATR+/−, ATR+/−ATM+/−, and
ATM+/− mice. Although no difference was observed in
the survival of ATR+/− mice in comparison to ATR+/−
ATM+/− mice, a decrease in the survival of both ATR+/−
and ATR+/−ATM+/− mice was observed in comparison to
that of ATM+/− mice. By 18 months, 10 of 48 ATR+/−
(21%) and 8 of 41 ATR+/−ATM+/− mice (20%) had died in
comparison to 1 of 22 ATM+/− mice (4.5%). Of the 10
ATR+/− and ATR+/−ATM+/− mice autopsied postmortem,
6 had evident tumors. The types of tumors observed
were histiocytic sarcoma (one in ATR+/−;
two in ATR+/−ATM+/−), large follicular
center cell lymphoma (ATR+/−), gastric
adenoma (ATR+/−ATM+/−), and sebaceous
gland adenoma (ATR+/−).
To further examine the tumor inci-
dence in these mice, autopsies were per-
formed on the remaining ATR+/−, ATR+/−
ATM+/−, and ATM+/− mice at 79–89 weeks
of age [mean age = 83 ± 3 (S.D.) weeks]. In
comparison to ATM+/− mice, a 4- and 2.6-
fold increase in tumor incidence was ob-
served in ATR+/− and ATR+/−ATM+/−
mice, respectively. In total, 5 of 25 ATR+/−
mice (20%), 4 of 30 ATR+/−ATM+/− mice
(13%), and 1 of 21 ATM+/− mice (4.8%)
had obvious tumors ranging from 1 to 3
cm in diameter. Comparison of the tumor
incidence in ATM+/− mice with that ob-
served in ATR+/− mice and in ATR+/− and
ATR+/−ATM+/− mice combined was sig-
nificant to P values of 0.050 and 0.045,
respectively. The types of tumors ob-
served were plasma cell lymphoma
(ATM+/−), mixed follicular center cell
lymphoma (two in ATR+/−; two in ATR+/−
ATM+/−), hepatocellular adenoma (one in
ATR+/−; one in ATR+/−ATM+/−), fibrous
histiocytoma (ATR+/−), ovarian cystade-
noma (ATR+/−), and ovarian fibroma
(ATR+/−ATM+/−). Although Southern blot
analysis of DNA extracted from ATR+/−
and ATR+/−ATM+/− tumors did not indi-
cate a loss of heterozygosity at the tar-
geted region of ATR (data not shown), it is
possible that alterations outside the targeted region may
have occurred in these tumors given the large size of the
ATR genomic locus (>60 kb). Together, these results in-
dicate that in contrast to heterozygosity of the ATM
gene, ATR heterozygosity causes a small decrease in sur-
vival and increase in tumor incidence.
ATR is required for early embryonic
cellular proliferation
To generate homozygous ATR-disrupted mice, ATR+/−
mice were intercrossed. However, of 225 progeny ana-
lyzed, no homozygous ATR-disrupted pups were ob-
served, implying that ATR is essential for embryonic de-
velopment. The stage at which ATR−/− embryos arrest in
development was then determined by isolation of em-
bryos from time-mated heterozygous crosses (Table 1).
Although an abnormally high number of decidua con-
tained embryos in the final stages of resorbtion, no viable
ATR−/− embryos were observed at day 7.5 postcoitum
(p.c.) or beyond. (Table 1). The high number of resorbed
embryos, however, suggested that ATR−/− embryos sur-
vive earlier stages of development and die following im-
plantion. To test whether ATR−/− embryos survive to the
blastocyst stage, embryos were isolated 3.5 days p.c. and
Figure 1. Targeted disruption of ATR. (A) A schematic of the wild-type locus,
targeting vector, and recombined locus are shown. In the targeting vector and
recombined locus, the neomycin selection cassette replaces the first three coding
exons of ATR, including the translation initiation codon (exon 1). Homologous
recombination of the targeting vector into the ATR locus introduces an EcoRV
site, shortening a 33-kb wild-type EcoRV fragment to 20 kb. (B) Southern blot of
DNA from ES cell colonies confirms the projected truncation of the EcoRV frag-
ment by homologous recombination. (Lanes 1,3) EcoRV-digested DNA from wild-
type ES cells, (lanes 2,4) ES cells with a single recombined ATR allele. (C) DNA
samples from wild-type (lanes 1,3) and ATR+/− (lanes 2,4) ES cells were subjected
to PCR to confirm genotyping as performed by Southern analysis. PCR products
derived from wild-type and disrupted alleles are 216 and 590 bp, respectively. (D)
Northern blot of poly (A)+ mRNA from ATR+/+ and ATR+/− MEFs. Embryos used
to generate MEFs (passage 2) were isolated from ATR-disrupted mouse lines 1 and
2 (see Materials and Methods). Autoradiographic detection of ATR, FRAP, and
b-actin transcripts are shown.
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genotyped. Of 83 embryos genotyped, 20 were ATR−/−.
Thus, ATR−/− embryos successfully develop to the blas-
tocysts stage but die subsequently, prior to E7.5.
To determine if the developmental defect in ATR−/−
mice was due to an inability of cells to proliferate sub-
sequent to the blastocyst stage, day 3.5 embryos were
isolated from ATR+/− intercrosses and grown in culture
for 6 days. After 1 day in culture, ATR+/+, ATR+/−, and
ATR−/− blastocysts hatched from the zona pellucida and
implanted onto the tissue culture plastic. At isolation
and during the first 2 days in culture, the inner cell mass
(ICM) of ATR−/− blastocysts was indistinguishable from
that of ATR+/+ and ATR+/− blastocysts. However,
while the ICM cells of ATR+/+ and ATR+/− em-
bryos continued to expand throughout the 6-day
culture period, ATR−/− ICM cells failed to expand
subsequent to day 2 and invariably died by day 4
in culture (Fig. 2A). Only the nondividing tropho-
blastic giant cells (TGC) of ATR−/− embryos re-
mained after 6 days in culture (Fig. 2A). Identical
results were observed with ATR−/− blastocysts
(n = 8) derived from an independent ATR-dis-
rupted line (line 2, data not shown).
The timing and cause of ATR−/− ICM cell death
was then explored by TUNEL staining of blasto-
cysts placed in culture for 48 or 72 hr. TUNEL
staining detects extensive DNA fragmentation
that results from apoptotic cell death. Although
few TUNEL-stained cells were observed in
ATR−/− blastocysts cultured for 48 hr, widespread
TUNEL staining was observed after 72 hr (Fig.
2B). A majority of the TUNEL-stained ATR−/−
cells was confirmed to be due to apoptosis
through the use of the caspase 3-inhibitor
Z-DEVD-FMK (Longthorne and Williams 1997).
Caspase-3 is a protease required for initiation of
apoptotic chromosome fragmentation following
exposure of ES cells and other cell types to a vast
array of DNA-damaging agents (Woo et al. 1998).
The potent inhibitor of caspase-3, Z-DEVD-FMK,
has been shown to inhibit Fas-induced apoptosis
in T cells (Longthorne and Williams 1997). As
shown, preincubation of ATR−/− blastocyst cells
with Z-DEVD-FMK inhibited the TUNEL stain-
ing observed after 48 and 72 hr of culture (Fig. 2B).
Overall, the number of TUNEL-stained cells in
ATR−/− blastocysts was reduced 80% by preincu-
bation with Z-DEVD-FMK. Consistent with
caspase-3 knockout studies (Woo et al. 1998), Z-
DEVD-FMK did not rescue ATR−/− cells from other mor-
phological effects of apoptosis such as changes in nuclear
morphology (Fig. 2B, day 3). These results demonstrate
that ATR is essential for expansion of early embryonic
cells in culture and that loss of ATR ultimately results in
apoptotic cell death.
Chromosome fragmentation in ATR−/− cells
Given the potential role of ATR in DNA replication and
damage checkpoints and DNA repair, we speculated that
the apoptotic signal in ATR−/− ICM cells may be initi-
ated by damaged DNA resulting from the lack of ATR. If
so, one would expect that such damage would occur
equally in the presence and absence of Z-DEVD-FMK. To
examine this possibility, mitotic spreads were prepared
from blastocysts grown for 48 hr in culture and then
treated with nocodazole or left untreated for 6 hr. The
number of mitotic cells in ATR−/− blastocyst cultures
increased significantly upon treatment with nocodazole,
indicating that ATR−/− cells attempt proliferation at day
2 in culture (Table 2). However, consistent with the hy-
pothesis that disruption of ATR causes a loss of genomic
Figure 2. Deletion of ATR leads to apoptotic death of early embryonic
cells. (A) Day 3.5 p.c. blastocysts were isolated from ATR+/− intercrosses
and were cultured in 96-well plates for 6 days. ICMs and TGC are indicated.
(B) TUNEL staining of ATR+/− and ATR−/− blastocysts cultured in the pres-
ence or absence of Z-DEVD-FMK. Blastocysts isolated from ATR+/− inter-
crosses were cultured in Terasaki-style microwell plates (Nunc) for 48 and
72 hr. Z-DEVD-FMK (200 µM) or vehicle was added after 24 hr of culture (for
48- and 72-hr time points) and added again after 48 hr (72-hr time point).
Fluorescein (TUNEL) and Hoechst fluorescent images are shown. (C) Ex-
amples of PCR genotyping of blastocysts cultured as described in A and B
are shown in panels 1 and 2, respectively.




(litters) +/+ +/− −/− Resorbed
P
values
10.5–14.5 23 (5) 9 14 0 N.D. 0.003
8.5–9.5 23 (4) 6 17 0 4 0.003
7.5 35 (5) 11 24 0 12 0.0003
P values were calculated by one tailed z-test. (N.D.) Not deter-
mined.
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integrity, chromosomal fragmentation was apparent in
>60% of the mitotic spreads from ATR−/− cells and ap-
peared equally with or without Z-DEVD-FMK pre-incu-
bation (Table 2). Thus, the Z-DEVD-FMK-resistant chro-
mosomal fragmentation observed in ATR−/− blastocysts
at day 2 in culture (Fig. 3) correlates to and is the likely
cause of the widespread caspase-dependent apoptosis ob-
served at day 3 (Fig. 2B). As shown, chromosome frag-
mentation ranged from mild (Fig. 3A) to extensive (Fig.
3B). This extensive mitotic DNA fragmentation (Fig. 3B)
may contribute to the residual caspase-independent
TUNEL staining observed in the presence of Z-DEVD-
FMK (discussed above); however, the degree of fragmen-
tation observed in a majority of mitotic spreads was ap-
parently beyond the limits of detection by TUNEL. Al-
though we cannot rule out the possibility that the
observed chromosome fragmentation in ATR−/− cells
may result from early stages of a caspase-independent
apoptotic process, these data are consistent with the hy-
pothesis that the aborted development of ATR−/− em-
bryos results from a loss of genomic integrity.
Discussion
We have found that disruption of the ATR gene leads to
a small increase in tumorigenesis in heterozygotes and
very early embryonic lethality in homozygotes. Al-
though the total incidence of tumors in ATR heterozy-
gotes was not as great as those observed in p53 hetero-
zygotes (Jacks et al. 1994), the effect of ATR heterozy-
gosity was statistically significant. It is interesting to
note that the incidence of large benign tumors was par-
ticularly increased in ATR heterozygotes. This increase
in benign tumors may indicate that deficiency in ATR
has a greater effect on the rate of tumor initiation than
on the rate of progression to malignancy. It is currently
not known whether ATR defects exist in humans; how-
ever the region to which ATR maps in humans is a site
of genetic alteration in lung cell carcinomas (Cimprich
et al. 1996)
As described here, our data indicate that ATR has an
essential role in preventing the occurrence of DNA dam-
age early in embryogenesis. Although recent studies sug-
gest that ATR regulates p53, defective regulation of p53
is unlikely to be the sole cause of such DNA damage, as
p53−/− mice do not suffer a block in early embryonic
development similar to that observed in ATR−/− mice.
Based on previous studies and data provided in this pa-
per, two plausible essential roles for ATR are apparent
and are discussed here: regulation of the BRCA gene
products and control of the S- to M-phase transition.
BRCA1 and BRCA2 regulation
Several lines of evidence have substantiated a link be-
tween ATR and the functions of BRCA1 and BRCA2.
BRCA1−/−, BRCA2−/−, and RAD51−/− mice die early in
development and have cellular proliferation defects
similar to that observed in ATR−/− cultured blastocysts
(Hakem et al. 1996; Lim and Hasty 1996; Sharan et al.
1997; Suzuki et al. 1997). Secondly, like ATR−/− cells,
chromosome breaks are observed in RAD51−/−, BRCA1
exon 11-deleted, and BRCA2-truncated cells (Lim and
Hasty 1996; Patel et al. 1998; Xu et al. 1999). Finally, the
ATR homolog ATM recently has been shown to be re-
quired for the phosphorylation of BRCA1 in response to
g-irradiation but is dispensable for BRCA1 phosphoryla-
tion in response to HU, MMS, and UV (Scully et al. 1997;
Cortez et al. 1999). Because ATR–KI expression renders
cells sensitive to these later reagents (Cliby et al. 1998;
Wright et al. 1998), it is possible that ATR and ATM
both regulate BRCA1 phosphorylation, albeit in a DNA
damage-specific manner. These genetics and biochemi-
cal similarities provide correlative evidence that the
Table 2. Mitotic index and analysis of mitotic spreads from






+/+ (4) − − 164 ± 95 1 ± 1 0
+/+ (6) + − 111 ± 67 25 ± 10 0
+/+ (5) + + 100 ± 14 21 ± 8 0
+/− (7) − − 158 ± 57 1 ± 0.8 0
+/− (7) + − 115 ± 41 23 ± 11 2 ± 3
+/− (6) + + 142 ± 47 20 ± 8 0
−/− (7) − − 133 ± 41 3 ± 2 60 ± 45
−/− (7) + − 79 ± 24 12 ± 5 64 ± 22
−/− (6) + + 81 ± 47 13 ± 7 65 ± 21
aThe number of blastocysts analyzed per condition are indicated
in parentheses.
bNocodazole.
cConfidence intervals (95%) are shown following the ± symbol.
Figure 3. Chromosomal fragmentation in ATR−/− cells at day 2
in culture. Chromosome fragmentation was observed ranging
from few (A) to many (B) breaks. This range of fragmentation
was observed similarly in ATR−/− blastocysts cultured in the
presence or absence of 200 µM Z-DEVD-FMK added after 24 hr
of culture.
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BRCA gene products may be dependent on ATR func-
tion.
S- to M-phase transition
A second plausible essential function for ATR is sug-
gested by the similarity between the extensive chromo-
somal fragmentation in ATR−/− cells (Fig. 3B) and that
observed in cells undergoing mitotic catastrophe. Mi-
totic catastrophe is caused by premature entry of cells
into mitosis prior to completion of DNA synthesis and is
characterized by a high degree of chromosomal fragmen-
tation (Heald et al. 1993; Schlegel and Pardee 1986). The
treatments and mutations that cause mitotic catastro-
phe are now recognized to influence a pathway that regu-
lates DNA damage and replication checkpoints in mam-
malian cells and S. pombe (Heald et al. 1993; Russell
1998; Chan et al. 1999; Pines 1999). Importantly, in S.
pombe this pathway requires RAD3, the closest known
relative of ATR (Cimprich et al. 1996; Keegan et al.
1996). Although recent studies indicate ATR may have a
redundant role with ATM in regulating this checkpoint
pathway in response to g-irradiation (Cliby et al. 1998;
Matsuoka et al. 1998; Chaturvedi et al. 1999), an essen-
tial role for ATR in DNA replication checkpoint re-
sponses has been implied (Cliby et al. 1998; Chaturvedi
et al. 1999; Sarkaria et al. 1999).
If ATR regulates a DNA replication checkpoint in
mammalian cells, mitotic catastrophe in ATR−/− cells
might be due to the lack of such a checkpoint combined
with the extremely rapid cellular proliferation that oc-
curs normally in the course of early embryonic develop-
ment. Early embryonic cells proliferate with doubling
times as short as 2 hr at day 6.5 p.c. (Snow 1977) and can
completely lack a G2 phase (Aladjem et al. 1998). Such
rapid proliferation indicates a high degree of precision in
transition from S to M phase. Thus, the chromosomal
fragmentation in ATR−/− cells might be due to an inabil-
ity to coordinate this transition accurately, resulting in
premature entry into mitosis. According to this analysis,
ATR may be dispensable in cells that cycle through a
more extensive G2 phase, but might be particularly es-
sential in the early embryo to sense incomplete DNA
replication and prevent mitotic catastrophe.
Materials and methods
Generation of the ATR targeted allele
A 17-kb genomic fragment encoding the amino terminus of murine ATR
was cloned from a 129SVJ genomic library (Stratagene). The ATR target-
ing vector was constructed by subcloning the 2.9-kb SalI and 7.5-kb XbaI
genomic fragments flanking the 6.5-kb ATR amino terminal encoding
fragment into the pPNT vector (Fig. 1A). ATR-disrupted ES cells cells
were generated in both D3 and J1 lines. A single targeted allele was
observed in 9 of 310 isolated ES cell colonies. Isolated colonies were
expanded and DNA was prepared by digestion in PK buffer (100 mM Tris
at pH 8.0, 400 mM NaCl, 5 mM EDTA, 0.8% SDS), followed by extraction
with one-third volume of saturated NaCl and precipitation in an equal
volume of isopropanol. EcoRV fragments were separated on a 0.66%
agarose gel and detected by Southern analysis using the indicated probe
(Fig. 1A). ATR-disrupted lines 1 and 2 are derived from J1 and D3 ES cell
lines, respectively. PCR genotyping was performed using a common
primer, 121 bp 58 of the initiating methionyl codon in exon 1 (58-ttccgg-
gaggagaattttggac-38) in combination with primers discriminating wild-
type exon 1-containing alleles (58-cggcgactcgaagctggcgacgacgc-38) and
knockout alleles encoding the 38 end of the neomycin resistance gene
(58-cagcgcatcgccttctatcgccttcttgac-38). PCR was performed in 25-µl reac-
tions with 1× PCR buffer (Boehringer Mannheim), 1.25 units of Taq poly-
merase, and 2% DMSO. Temperature cycling conditions were (1) 94°C
for 4 min, (2) 94°C for 1 min, (3) 62°C for 2.5 min, and (4) 72°C for 2.5
min, cycling 33 times to step 2. Poly (A)+ mRNA from ES cells and day
14.5 MEFs was isolated, subjected to Northern blot analysis, and probed
with the full-length human ATR cDNA (Cimprich et al. 1996). Normal-
ization was performed upon subsequent probing with the full-length
cDNAs for FRAP (Brown et al. 1994) and b-actin (Clontech). Levels of
mRNA were quantitated by PhosphorImager readout (Molecular Dynam-
ics), and 95% confidence intervals for the average reduction of normal-
ized ATR mRNA levels were calculated by Student’s t-test.
Survival of and tumors in ATR+/− mice
ATR+/− and ATM+/− of 129Sv and C57BL/6 mixed background were in-
tercrossed to produce populations of ATR+/−, ATR+/−ATM+/−, and
ATM+/− mice. Mice suffering from severe fighting wounds (~ 10%) were
excluded from further study. The percentages of deceased and euthanized
mice from ATR+/− and ATR+/−ATM+/− populations were compared to
that of ATM+/− by Kaplan–Meier analysis, and log-rank P values were
calculated (Biostat 2000, Cupertino, CA). Individual comparison of
ATR+/− and ATR+/−ATM+/− survival with ATM+/− survival was signifi-
cant to P values of 0.067 and 0.097, respectively. Histopathology on
formalin-fixed tissues was performed by the Research Animal Diagnostic
and Investigative Laboratory (Columbia, MO). Test significance of dif-
ference in tumor incidence for animals autopsied 79–89 weeks of age was
calculated by one tailed z-test.
Cultured blastocysts and TUNEL assays
Blastocysts were flushed from the uterus of ATR+/− females 3.5 days p.c.
and washed five times in M2 media (Sigma) or PBS containing 5% FBS.
Blastocysts were cultured for the times indicated in 50 µl (Fig. 2A) or 15
µl (Fig. 2B) of DMEM containing 15% FBS, 100 µM b-mercaptoethanol, 2
mM glutamine, 100 µM nonessential amino acids, and 1× penicillin/strep-
tomycin (GIBCO–BRL). Z-DEVD-FMK (200 µM) or vehicle was added
after 24 and 48 hr (72-hr time point) of culture. At 200 µM, Z-DEVD-FMK
has been shown to completely prevent Fas-induced apoptosis in human
cells without affecting cellular proliferation (Longthorne and Williams
1997). For TUNEL assay, blastocysts were fixed at the indicated times in
3% paraformaldyhyde/PBS for 30 min. Permeabilization and TUNEL
assays were performed using the In Situ Cell Death Detection Kit, Fluo-
rescein (Boehringer Mannheim) as per the manufacturer’s instructions.
For PCR genotyping, DNA was prepared by incubation of individual
blastocysts with 1.5 µl of NSPK buffer [300 µg/ml proteinase K (Boeh-
ringer Mannheim), 100 mM KCl, 20 mM Tris at pH 8.0, 4 mM MgCl2, 0.9%
NP-40, 0.9% Triton X-100] for 4 hr at 60°C, followed by incubation at
90°C for 30 min. The entire DNA isolate was used directly for PCR,
which was performed as described for Figure 1C. PCR products were then
Southern blotted and probed with a 32P end-labeled internal primer com-
mon to both wild-type and mutant PCR products (58-gacctcgcggggctcc-
gtcga-38). Hybridized products were detected by autoradiography.
Preparation of mitotic spreads and genotyping
Blastocysts were grown in 96-well round-bottom plates as described (Fig.
2A) and treated with 200 µM Z-DEVD-FMK or vehicle (0.1% DMSO) after
24 and 48 hr in culture. At 48 hr in culture, blastocysts were treated with
2.5 µM nocodazole for 6 hr and subsequently processed for preparation of
mitotic spreads. To suspend cells, blastocysts were washed twice in PBS
and trypsinized in 30 µl of 0.25% trypsin/1 mM EDTA (GIBCO–BRL).
Trypsin was then neutralized with 150 µl of culture media and, cells
were tritriated and transferred to 200-µl micocentrifuge tubes. At this
step, 60 µl of the cell suspension was transferred to a separate tube for
PCR analysis (below). The remaining 120-µl cell suspension was washed
once in PBS (250 g centrifugation), resuspended in 75 mM KCl, and in-
cubated at room temperature for 20 min. Cells were then centrifuged at
500g, resuspensed in ice-cold 3:1 (vol/vol) methanol/acetic acid fixative,
incubated at 4°C for 10 min, and centrifuged at 650g. The fixation steps
were repeated once, and cells were resuspended in 15 µl of fixative and
dropped onto prewarmed (37°C) glass slides. Slides were stained with
Hoechst or Giemsa, and mitotic and interphase cells were counted. Con-
fidence intervals (95%) were calculated by Student’s t-test. For genotyp-
ATR disruption causes early embryonic lethality
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ing, cells (60 µl, above) were washed five times with PBS (250g centrifu-
gation). All centrifugation steps in these procedures were for 5 min. The
final cell pellet was resupended in 1.5 µl of NSPK buffer, and DNA was
isolated and PCR genotyped as described above.
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